October 22, 2021
Manuel Carrondo, Vice-President of iBET, shared expert insights on Cell and Gene Therapy in two interviews to The Video Journal of Regenerative Medicine. Both interviews occurred in the scope of the Advanced Therapies Congress & Expo 2021 meeting and covered:
- Overview of the current landscape of viral vector-based gene therapy
- Comparison of viral vector-based gene therapy with antibody-based cancer therapy
- Importance of developing analytical tools to improve the characterization and quality control of viral vector-based Gene and Cell therapies
- Trends on analytical tools being developed using machine learning and artificial intelligence (AI)
Interview 1 – “The current landscape of viral vector-based gene therapy”
[Click the image to see the full interview]
Interview 2 – “The importance of analytical tools in cell and gene therapy manufacturing”
[Click the image to see the full interview]